Poly Medicure Past Earnings Performance
Past criteria checks 4/6
Poly Medicure has been growing earnings at an average annual rate of 23.4%, while the Medical Equipment industry saw earnings growing at 21% annually. Revenues have been growing at an average rate of 16.3% per year. Poly Medicure's return on equity is 17.6%, and it has net margins of 18.8%.
Key information
23.4%
Earnings growth rate
21.2%
EPS growth rate
| Medical Equipment Industry Growth | 23.0% |
| Revenue growth rate | 16.3% |
| Return on equity | 17.6% |
| Net Margin | 18.8% |
| Last Earnings Update | 31 Mar 2024 |
Recent past performance updates
Recent updates
Poly Medicure's (NSE:POLYMED) Promising Earnings May Rest On Soft Foundations
May 25
Why You Should Care About Poly Medicure's (NSE:POLYMED) Strong Returns On Capital
May 12Poly Medicure Limited's (NSE:POLYMED) Share Price Not Quite Adding Up
Mar 23Here's Why We Think Poly Medicure (NSE:POLYMED) Might Deserve Your Attention Today
Feb 15Poly Medicure (NSE:POLYMED) Seems To Use Debt Quite Sensibly
Jan 16Is Now The Time To Put Poly Medicure (NSE:POLYMED) On Your Watchlist?
Nov 14Poly Medicure (NSE:POLYMED) Has More To Do To Multiply In Value Going Forward
Oct 24Shareholders Will Probably Hold Off On Increasing Poly Medicure Limited's (NSE:POLYMED) CEO Compensation For The Time Being
Sep 22Poly Medicure (NSE:POLYMED) Is Increasing Its Dividend To ₹3.00
Sep 08Here's Why Poly Medicure (NSE:POLYMED) Can Manage Its Debt Responsibly
Aug 12Here's Why We Think Poly Medicure (NSE:POLYMED) Is Well Worth Watching
Jul 13Poly Medicure (NSE:POLYMED) Is Reinvesting At Lower Rates Of Return
Jun 16Be Wary Of Poly Medicure (NSE:POLYMED) And Its Returns On Capital
Mar 02We Think Poly Medicure (NSE:POLYMED) Can Stay On Top Of Its Debt
Feb 14Capital Allocation Trends At Poly Medicure (NSE:POLYMED) Aren't Ideal
Oct 16We Think Poly Medicure (NSE:POLYMED) Can Stay On Top Of Its Debt
Sep 28Poly Medicure (NSE:POLYMED) Has Affirmed Its Dividend Of ₹2.50
Sep 08Here's Why Poly Medicure (NSE:POLYMED) Can Manage Its Debt Responsibly
Jun 25A Look At The Intrinsic Value Of Poly Medicure Limited (NSE:POLYMED)
Jun 07Poly Medicure (NSE:POLYMED) Will Want To Turn Around Its Return Trends
May 23With EPS Growth And More, Poly Medicure (NSE:POLYMED) Is Interesting
Feb 23There Are Reasons To Feel Uneasy About Poly Medicure's (NSE:POLYMED) Returns On Capital
Feb 04Poly Medicure (NSE:POLYMED) Seems To Use Debt Quite Sensibly
Jan 12With EPS Growth And More, Poly Medicure (NSE:POLYMED) Is Interesting
Oct 14Poly Medicure (NSE:POLYMED) Could Easily Take On More Debt
Jul 07Poly Medicure (NSE:POLYMED) Will Will Want To Turn Around Its Return Trends
Jun 18Poly Medicure's (NSE:POLYMED) Solid Profits Have Weak Fundamentals
May 31Earnings Update: Here's Why Analysts Just Lifted Their Poly Medicure Limited (NSE:POLYMED) Price Target To ₹1,195
May 26Shareholders of Poly Medicure (NSE:POLYMED) Must Be Delighted With Their 448% Total Return
Mar 01I Ran A Stock Scan For Earnings Growth And Poly Medicure (NSE:POLYMED) Passed With Ease
Feb 16How Much Is Poly Medicure Limited (NSE:POLYMED) CEO Getting Paid?
Feb 01Did Poly Medicure Limited (NSE:POLYMED) Insiders Sell Shares?
Jan 17Poly Medicure Limited's (NSE:POLYMED) Stock Is Going Strong: Is the Market Following Fundamentals?
Dec 09
Announcing: Poly Medicure (NSE:POLYMED) Stock Increased An Energizing 205% In The Last Five Years
Nov 24Is Poly Medicure (NSE:POLYMED) Using Too Much Debt?
Nov 09Many Would Be Jealous Of Poly Medicure's (NSE:POLYMED) Returns On Capital
Oct 26Have Insiders Been Selling Poly Medicure Limited (NSE:POLYMED) Shares?
Oct 06Should You Be Adding Poly Medicure (NSE:POLYMED) To Your Watchlist Today?
Sep 17Should Poly Medicure Limited (NSE:POLYMED) Be Part Of Your Dividend Portfolio?
Sep 02Revenue & Expenses Breakdown
Revenue & Expenses Breakdown
How Poly Medicure makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Mar 24 | 13,758 | 2,583 | 2,459 | 190 |
| 31 Dec 23 | 13,046 | 2,487 | 2,349 | 198 |
| 30 Sep 23 | 12,498 | 2,337 | 2,278 | 193 |
| 30 Jun 23 | 11,872 | 2,150 | 2,151 | 182 |
| 31 Mar 23 | 11,152 | 1,793 | 2,076 | 178 |
| 31 Dec 22 | 10,659 | 1,566 | 1,979 | 171 |
| 30 Sep 22 | 10,113 | 1,411 | 1,866 | 178 |
| 30 Jun 22 | 9,600 | 1,359 | 1,751 | 188 |
| 31 Mar 22 | 9,231 | 1,465 | 1,671 | 188 |
| 31 Dec 21 | 8,785 | 1,492 | 1,590 | 174 |
| 30 Sep 21 | 8,518 | 1,500 | 1,544 | 159 |
| 30 Jun 21 | 8,280 | 1,468 | 1,489 | 140 |
| 31 Mar 21 | 7,865 | 1,359 | 1,448 | 131 |
| 31 Dec 20 | 7,448 | 1,197 | 1,434 | 129 |
| 30 Sep 20 | 7,218 | 1,094 | 1,409 | 124 |
| 30 Jun 20 | 6,960 | 1,028 | 1,359 | 121 |
| 31 Mar 20 | 6,872 | 959 | 1,431 | 119 |
| 31 Dec 19 | 6,881 | 947 | 1,427 | 97 |
| 30 Sep 19 | 6,625 | 858 | 1,377 | 98 |
| 30 Jun 19 | 6,388 | 719 | 1,229 | 100 |
| 31 Mar 19 | 6,108 | 654 | 1,224 | 101 |
| 31 Mar 18 | 5,204 | 706 | 1,035 | 100 |
| 31 Mar 17 | 4,550 | 551 | 931 | 90 |
| 31 Mar 16 | 4,123 | 483 | 791 | 87 |
| 31 Mar 15 | 3,903 | 623 | 687 | 85 |
| 31 Mar 14 | 3,222 | 451 | 784 | 59 |
Quality Earnings: POLYMED has a high level of non-cash earnings.
Growing Profit Margin: POLYMED's current net profit margins (18.8%) are higher than last year (16.1%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: POLYMED's earnings have grown significantly by 23.4% per year over the past 5 years.
Accelerating Growth: POLYMED's earnings growth over the past year (44.1%) exceeds its 5-year average (23.4% per year).
Earnings vs Industry: POLYMED earnings growth over the past year (44.1%) exceeded the Medical Equipment industry 36.1%.
Return on Equity
High ROE: POLYMED's Return on Equity (17.6%) is considered low.